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Abstract
Background: Congenital heart defects are frequently observed in infants of diabetic mothers, but
the molecular basis of the defects remains obscure. Thus, the present study was performed to gain
some insights into the molecular pathogenesis of maternal diabetes-induced congenital heart
defects in mice.
Methods and results: We analyzed the morphological changes, the expression pattern of some
genes, the proliferation index and apoptosis in developing heart of embryos at E13.5 from
streptozotocin-induced diabetic mice. Morphological analysis has shown the persistent truncus
arteriosus combined with a ventricular septal defect in embryos of diabetic mice. Several other
defects including defective endocardial cushion (EC) and aberrant myofibrillogenesis have also been
found. Cardiac neural crest defects in experimental embryos were analyzed and validated by the
protein expression of NCAM and PGP 9.5. In addition, the protein expression of Bmp4, Msx1 and
Pax3 involved in the development of cardiac neural crest was found to be reduced in the defective
hearts. The mRNA expression of Bmp4, Msx1 and Pax3 was significantly down-regulated (p < 0.001)
in the hearts of experimental embryos. Further, the proliferation index was significantly decreased
(p < 0.05), whereas the apoptotic cells were significantly increased (p < 0.001) in the EC and the
ventricular myocardium of the experimental embryos.
Conclusion: It is suggested that the down-regulation of genes involved in development of cardiac
neural crest could contribute to the pathogenesis of maternal diabetes-induced congenital heart
defects.
Background
Maternal diabetes mellitus is associated with a five fold
increase in risk of cardiovascular malformations in infants
of diabetic mothers [1]. These malformations include
endocardial cushion (EC) defects, persistent truncus arte-
riosus (PTA) and ventricular septal defects (VSD) which
appear to result from aberrant cardiac neural crest devel-
opment [1-3]. Several studies have used animal models to
examine the diabetes-induced congenital malformations
during development of brain, heart and blood vessels [4-
6]. However, the molecular mechanisms by which the ter-
atogenicity of maternal diabetes causes congenital heart
defects in embryos remain undefined.
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During development, cells from the neural crest over the
occipital somites (cardiac neural crest cells; CNCC)
migrate to the heart to give rise to parasympathetic post-
ganglionic neurons (cardiac ganglia) as well as ectomes-
enchymal elements contributing to conotruncal septation
in the chick embryo [7,8]. Ablation of the CNCC in chick
embryos results in PTA accompanied by a decrease (30%)
in the parasympathetic postganglionic innervation of the
heart [9]. In mammalian embryos, a similar population of
CNCC exists and is perturbed in a number of genetic and
teratogenic contexts [10]. Maternal diabetes induced con-
genital heart defects appear to be similar to the neural
crest ablation model [11] since it has been shown that
high glucose concentration inhibits migration of neural
crest-derived cells from the neural tube in rat embryos
[12]. The migration and differentiation of the CNCC into
cardiac ganglia are influenced by various developmental
control genes. Neural cell adhesion molecule (NCAM)
plays a critical role during the development of the avian
EC [13]. NCAM expressed early in neural crest formation
disappears as migration is initiated and it reappears when
CNCC are induced to form cardiac ganglia at the end of
their migration [14]. Protein gene product 9.5 (PGP 9.5)
appears to be one of the earliest neuron specific genes to
be expressed in the developing nervous system. The
expression pattern of PGP9.5 closely matches that of the
late phase expression of the NCAM [15]. Our recent study
in embryonic rat hearts hypothesized that a teratogen
such as retinoic acid has an effect on the CNCC resulting
in disruption of the differentiation of the cardiac ganglia
[16]. In the present study, we speculate that expression of
genes controlling normal cardiac ganglia development is
altered by maternal diabetes, thereby leading to disrup-
tion of the differentiation of the cardiac ganglia.
Maternal diabetes has been shown to induce generalized
defects in CNCC development in some, presumably
genetically predisposed, individuals among the offspring
[17]. Mutations in some genes that control the cardiogen-
esis result in the congenital heart defects [18-22]. These
genes, however have not been linked to congenital heart
defects in diabetic offspring. Bone morphogenetic protein
4 (Bmp4) has been implicated as regulator of CNCC
induction, maintenance, migration, differentiation and
survival. It is also required in CNCC for development of
the outflow tract (OFT) and ventricular myocardium [23].
It has been shown to be involved in many developmental
processes including epithelial mesenchymal transforma-
tion (EMT), controls proliferation index in the atrioven-
tricular (AV) cushion during heart development [24,25].
Mutation of Bmp4 reduces proliferation index in the AV
cushion, leading to AV canal defects [18]. Mouse Msx1,
which shares homology with the Drosophila muscle seg-
ment homeobox (msh) gene, is expressed in a number of
non-myocardial cell populations, including cells under-
going an EMT in the AV septum and the OFT region. Msx1
has been shown to play an integral role in heart septation
and valve formation [26]. Mutation in Msx1/2 causes pro-
found deficiencies in the development of structures
derived from the cranial and cardiac neural crest [19,20].
The cardiac neural crest-derive aortico-pulmonary septum
that divides the distal portion of the OFT into ascending
aorta and pulmonary trunk [27]. Pax3, a paired-box gene,
is required for the migration of CNCC to the developing
great vessels. It has been reported that Pax3 mutant mice,
the naturally occurring splotch mutation, suffer from a
PTA [22]. Based on the above facts, it is hypothesized that
expression pattern of genes that are involved in the devel-
opment of cardiac neural crest is altered, leading to con-
genital heart defects in embryos of diabetic pregnancy.
Therefore, the present study was carried out by analyzing
the expression pattern of those genes and morphological
changes to understand the possible mechanisms causing
congenital heart defects in the embryos of diabetic preg-
nancy.
Methods
Experimental Animals
The Swiss Albino mice used in the present study were
obtained from the Laboratory Animals Centre, Singapore.
Diabetes mellitus was induced in 8 week-old female mice
by an intraperitoneal injection of streptozotocin (STZ, 75
mg/kg body weight, Sigma, USA) dissolved in citrate
buffer (0.01 M, pH 4.5) on three successive days. Blood
glucose levels were examined one week after STZ injection
using a Glucometer Elite (Bayer, USA). Only mice with
non-fasting blood glucose level exceeding 16 mmol/l
were used as experimental diabetic mice. In contrast, con-
trol mice maintained the normal blood glucose levels (4–
6 mmol/l) before and during pregnancy. Timed mating
was carried out by placing four female mice with one nor-
mal male mouse in a cage overnight. Noon on the day on
which a copulation plug was observed was counted as
embryonic day 0.5 (E0.5). On E13.5 (about 60 pairs of
somites), pregnant mice were anaesthetized with pento-
barbital (150 mg/kg body wt, intraperitoneally) and
embryos were collected after Caesarean section. A total of
180 embryos (E13.5) were used for this study. Of these,
120 and 60 embryos were obtained from diabetic (n = 15)
and control (n = 6) mothers respectively. The develop-
mental stage, E13.5 was chosen for this study, as it corre-
sponds to ~6 weeks of human gestation [28,29], when all
4 chambers of the heart were clearly distinguishable, and
the outflow tract was evident [30]. In addition, the heart
phenotype was apparent in embryos from diabetic mice.
Embryos with malformations from diabetic mice and nor-
mal embryos from non-diabetic mice were used as the
experimental and control groups, respectively. All proce-
dures involving animals handling were in accordance
with the Principles of Laboratory Animal Care (NIH pub-Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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lication no. 85-23, revised 1985) and guidelines of the
Institutional Animal Care and Use Committee (IACUC),
National University of Singapore.
Histology and Immunohistochemistry
Embryonic tissues were fixed with 4% paraformaldehyde
(PF) in phosphate buffer (PB) at 4°C overnight, dehy-
drated and embedded in paraffin. Sections (5 µm thick)
were stained with hematoxylin and eosin. For cryostat sec-
tioning, tissues were fixed in 4% PF in PB at 4°C overnight
and cryoprotected with 20% sucrose. The method for
immunohistochemical analysis was adapted from Kumar
and Tay [31]. Transverse or sagittal sections (20 µm thick)
of the tissues were cut using a cryostat (Leica CM 3050,
Leica Microsystems, Nussloch, Germany), washed with
phosphate buffered saline (PBS) and blocked in 5% nor-
mal serum for 1 h at room temperature (RT). The sections
were then incubated overnight with rabbit polyclonal
PGP9.5 (1: 400; UltraClone Ltd, UK) or mouse mono-
clonal NCAM (1:100; Chemicon International, CA, USA),
Bmp4 (1:100; Chemicon International, CA, USA), Msx1
(1: 100; Santa Cruz Biotechnology, Inc) and Pax3 super-
natant (1:10; Developmental Studies Hybridoma Bank,
University of Iowa) in PBS containing 0.1% Triton X-100
(PBS-TX). Sections were washed in PBS and incubated in
the anti-rabbit IgG or anti-mouse IgG for 1 h at RT. The
sections were subsequently processed using ABC kit (Vec-
tor Laboratories, Burlingame, CA, USA) for 1 h at RT, and
reaction products were finally visualized using 3, 3-diami-
nobenzidine tetrahydrochloride (DAB; Sigma, St. Louis,
MO) as the substrate. Tissue sections were counterstained
by 0.5% methyl green nuclear stain for 10 minutes, dehy-
drated by immersion in alcohol and then cleared with
xylene before mounting in medium (Permount; Fisher
Scientific, Pittsburgh, PA). Control sections were incu-
bated as described above but without the primary anti-
body. Photomicrographs were taken with a light
microscope (Olympus BX51, Olympus, Japan).
Confocal microscopy
The cryocut sections (20 µm thick) were treated with 1%
hydrogen peroxide in methanol to inactivate endogenous
peroxidase. The sections were then washed with PBS and
incubated overnight with the following primary antibod-
ies: mouse Bmp4 (1:100; Chemicon International, CA,
USA), Msx supernatant (1:10; Developmental Studies
Hybridoma Bank, University of Iowa) and Pax3 superna-
tant (1:10; Developmental Studies Hybridoma Bank, Uni-
versity of Iowa) in PBS-TX. Sections were washed in PBS
and incubated in the anti-mouse IgG conjugated to FITC
(1: 200; Sigma) or anti-mouse IgG conjugated to Cy3
(1:200, Sigma) diluted in PBS-TX accordingly for 1 h at
RT. Control sections were incubated as described above
but without the primary antibodies. Double immunoflu-
orescence labeling was carried out for the localization of
cardiac ganglia and CNCC in the embryonic hearts. Cryo-
sections were rinsed in PBS and incubated with rabbit pol-
yclonal PGP9.5 (1: 400; UltraClone Ltd, UK) and mouse
monoclonal NCAM (1:100; Chemicon International, CA,
USA) overnight at RT. The sections were then washed and
incubated in anti-rabbit IgG conjugated to Cy3 (1:200,
Chemicon, USA) and anti-mouse IgG conjugated to FITC
(1:200, Chemicon, USA) for 1 h at RT. Sections were
finally mounted with fluorescent mounting medium
(DAKO, USA). The tissue sections were viewed and photo-
images were captured in a confocal laser scanning micro-
scope equipped with a digital camera (Olympus FV1000,
Japan).
Quantitative real-time RT-PCR
Total RNA from three samples at E13.5 of control and dia-
betic embryonic hearts was extracted using RNeasy mini
kit (Qiagen, Hilden, Germany). The reaction mixture con-
taining 2 µg of RNA, 2.5 µM oligo (dT) primer, 200 U of
molony murine leukemia virus reverse transcriptase (M-
MLV, Promega, USA), 2 mM of each dNTPs, 5 U of RNasin
in a total volume of 25 µl was incubated for 1 h at 42°C
to synthesize cDNAs. For real time RT-PCR, aliquots (5 µl)
of cDNA products were amplified in the reaction mixture
(20 µl) containing LightCycler FastStart DNA Master SYBR
Green I, 0.5 µM of each primer in a LightCycler instru-
ment (Roche Molecular Biochemicals, Germany) as
instructed by the manufacturer. The primers used in this
study were shown in Table 1. The fold change of mRNA
was analyzed by 2-∆∆Ct method [32].
Table 1: Primers and thermal profiles for real-time RT-PCR.
Gene GenBank Accession No. Primer Product size (bp) Annealing temp./time (°C/s) Extension temp./time (°C/s)
β-actin NM_007393 5'-tgttaccaactgggacgaca-3'
5'-ggggtgttgaaggtctcaaa-3'
165 55/7 72/20
Bmp4 NM_007554 5'-tgatacctgagaccgggaag-3'
5'-agccggtaaagatccctcat-3'
190 55/8 72/20
Msx1 NM_010835 5'-agctctgctgccctatacca-3'
5'-cttggcctctgcatccttag-3'
205 57/8 72/20
Pax3 NM_008781 5'-ctgcactcaagggactcctc-3'
5'-gtgaaggcgagacgaaaaag-3'
169 57/7 72/20Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Proliferation index by BrdU labeling
Pregnant mice from the control and diabetic groups (n =
3 in each group) were injected intraperitoneally with
BrdU (100 mg/kg body weight, Sigma, USA) 2 h before
the embryos were collected by Caesarean section. Frozen
sections at the level of the heart were cut (10 µm thick),
rinsed in PB (pH 7.4), incubated with 2 mol/l HCl at
37°C for 30 min, then blocked in mouse IgG blocking
reagent (Vector Laboratories, Burlingame, CA, USA) for 1
h, and incubated with anti-BrdU monoclonal antibody
(1:1000, Sigma, USA) overnight at RT. Subsequently, sec-
tions were washed and incubated in biotinylated anti-
mouse IgG and ABC kit (Vector Laboratoies, Burlingame,
CA, USA). Finally, the reaction products were visualized
using DAB (Sigma, St. Louis, MO) as the substrate. The tis-
sue sections were counter-stained with 1% methyl green
and mounted in Permount. Photomicrographs were taken
with a light microscope (Olympus BX51). The prolifera-
tion index was determined by counting the BrdU-positive
cells in relation to total cells in every third sagittal section
of the heart under a ×20 objective for each group (control
and diabetic) in each independent experiments. The pro-
liferation index is expressed as mean ± SD of the percent-
age of BrdU-positive cells. Identification of
cardiomyocytes was confirmed histologically by their
characteristic and distinct morphology. The total number
of BrdU-positive cells in the embryonic heart between
control and diabetic group was compared statistically
using Student's t test. Differences were considered statisti-
cally significant at p < 0.05. The procedure used for prolif-
erating cell count in embryos of diabetic mice was
previously described [33].
Detection of apoptosis by TUNEL assay
Terminal deoxynucleotidyltransferase [TdT]-mediated
dUTP nick end labelling (TUNEL) assay was performed
with an in situ cell death detection Kit (Roche), according
to the manufacturer's instruction. Briefly, the cryosections
(10 µm thick) were incubated with TUNEL reaction mix-
ture containing the terminal deoxynucleotidyltransferase
for 60 min at 37°C. Tissues were rinsed with PBS and
incubated with DAB substrate for 10 min. The apoptotic
cells were counted and the data are presented as the per-
centage of TUNEL positive cells relative to the total
number of cells. The method for apoptotic cell counts in
embryos of diabetic mice as described previously [34].
Transmission electron microscopy (TEM)
The normal embryos from control mice and the defective
embryos from diabetic mice (n = 3 in each group) were
used for TEM studies. The method for TEM analysis was
adapted from Kumar and Tay [35]. Embryos were fixed in
4% PF and 3% glutaraldehyde in PB at 4°C overnight.
Briefly, the embryonic heart was dissected into small
pieces of tissue samples under the light microscope. The
specimens were sampled from the myocardium of entire
ventricular wall from both groups. The tissues were then
post-fixed in 1% OsO4 in 0.1 M PB for 1 h, dehydrated in
a graded series of ethanol and finally embedded in Arald-
ite. Ultrathin sections obtained were double stained with
lead citrate and uranyl acetate and viewed under a Philips
CM120 electron microscope. The TEM analysis was per-
formed in the embryonic hearts of experimental mice as
described previously [36,37].
Statistical Analysis
The results were analyzed by a two-tailed Student's t test
using Microsoft Excel software and expressed as means ±
SD. Differences were considered statistically significant at
p < 0.05.
Results
Female Swiss Albino mice were rendered diabetic by STZ
at 4 weeks before the beginning of pregnancy. The dia-
betic female mice were mated with normal male mice and
examined daily for the presence of copulation plugs. Only
those mice with non-fasting blood glucose level exceeding
16 mmol/l were used as experimental mice. Control ani-
mals maintained the normal blood glucose levels (4–6
mmol/l) before and during pregnancy. A total of 180
embryos (E13.5) were used for this study. Of these, 120
and 60 embryos were obtained from diabetic (n = 15) and
control (n = 6) mothers respectively (Table 2). The
number of embryos per litter was significantly reduced (p
< 0.001) in diabetic mothers (8 ± 1.2) when compared to
controls (10 ± 0.6; Table 2). In addition, the frequency of
empty deciduas was found to be 15% in diabetic pregnan-
cies (Table 2). About 10% of embryos from diabetic mice
showed a range of cardiac malformations (Table 3). Most
of them (7.5%) had a PTA (Fig. 1E) combined with VSD
(Fig. 1F, 3D, 3Q). About 2.5% of the embryos showed EC
defects (defective AV septum with defective valve develop-
ment; Fig. 3I) (Table 4). Embryos from diabetic mice also
displayed the extra-cardiac malformation (12.5%), such
as neural tube defects, including exencephaly, anaenceph-
aly and spina bifida (Table 3). Although embryos of dia-
betic pregnancies appeared smaller than embryos from
non-diabetic pregnancies (as determined by crown-rump
length), they were not developmentally delayed (as deter-
mined by somite number). The myocardium and trabecu-
Table 2: Number (mean ± SD) of embryos and empty deciduas 
obtained from the control and diabetic mice.
Control Diabetes
No. of animals studied 6 15
Total No. of embryos studied 60 120
No. of embryos per litter 10 ± 0.6 8 ± 1.2*
No. of empty deciduas per pregnancy 0 1.2 ± 0.8
* p < 0.001 (Student's t test)Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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lae appear to be disarranged and the epicardium was
disorganized in embryos of diabetic pregnancy (Fig. 1F)
when compared to controls (Fig 1C). The development of
cardiac innervation and ganglionic cells were examined
by localization of immunoreactivities of PGP 9.5 and
NCAM in embryos from diabetic and control mice. Exper-
imental embryos showed a decrease in the number of car-
diac ganglionic cells expressing PGP 9.5 around the great
vessels on the posterior atrial wall (Fig. 2C, D) when com-
pared with controls (Fig. 2A, B). The NCAM immunoreac-
tivity appeared to be down-regulated in the nerves and
ganglia around the atrial epicardium in embryos of dia-
betic mice (Fig. 2G, H) when compared with those of the
controls (Fig. 2E, F). In addition, the number of cardiac
ganglionic cells expressing PGP 9.5 and NCAM immuno-
reactivities in the atrial epicardium appeared to be
reduced in embryos from diabetic mice (Fig. 2H) when
compared to controls (Fig. 2F).
In embryos of control mice, Bmp4 immunoreactivity was
expressed in the muscular layer of the OFT and its deriva-
tives (aorta/pulmonary trunk). It was also detected in car-
diomyocytes overlying the EC and in the ventricular
septum (Fig. 3a–c), as previously described by Jiao et al.
[18]. In contrast, Bmp4 expression was reduced in the
OFT and in cardiomyocytes overlying the EC in embryos
from diabetic mice (Fig. 3D–F). Real-time RT-PCR analy-
sis revealed a significant decrease in the mRNA expression
of Bmp4 in embryos of diabetic pregnancy when com-
pared to controls (Fig. 4; p < 0.001). Consistent with the
histological analysis (Fig. 1F), embryos from experimen-
tal mice displayed VSD (Fig. 3D). In normal embryos,
Msx1 was strongly expressed in endocardial cells in the AV
canal and in the EC mesenchymal cells (Fig. 3G, H). In
embryos with AV canal defects from diabetic mice, Msx1
expression was absent in endocardial cells of the AV canal
and the number of Msx1 positive mesenchyme cells in the
EC was reduced (Fig. 3I, J). Furthermore, the mRNA
expression level of Msx1 was significantly decreased in
embryos of diabetic mice when compared to controls (Fig.
4; p < 0.001). In control embryos, Pax3 positive cells were
localized around the atrial epicardium, OFT, and in the
EC (Fig. 3K–O). In contrast, in embryos with VSD, the
number of Pax3 positive cells was notably reduced in the
atrial epicardium, OFT and in the EC (Fig. 3P–S). In addi-
tion, the mRNA expression level of Pax3 was significantly
decreased in embryos of diabetic mice when compared to
controls (Fig. 4; p < 0.001). TUNEL assay showed that the
percentage of apoptotic cells in EC and in the ventricular
myocardium was significantly increased in the embryos of
diabetic mice when compared to controls (Fig. 5A–E; p <
0.001). In addition, the total number of BrdU-positive
cells in the EC and the ventricular myocardium was signif-
icantly decreased in embryos of diabetic mice when com-
pared to controls (Fig. 6A–E; p < 0.05).
The ultrastructure of cardiomyocytes in the embryos of
control mice and the embryos of diabetic mice was also
examined (Fig. 7). The cardiomyocytes of the ventricular
wall from the malformed heart showed some ultrastruc-
tural changes which include swollen mitochondria (Fig.
7C) and decreased number of myofilaments (Fig. 7D)
when compared to controls (Fig. 7A, B). In addition, the
adherence junctions were poorly developed, with detach-
ments of myofilaments. The desmosomes had developed
normally and were indistinguishable from those of the
normal controls (Fig. 7D).
Discussion
Cardiac anomalies are one of the most common malfor-
mations in offspring of diabetic mothers [38,39]. This
study attempts to reveal the molecular and morphological
changes contributing to congenital heart defects in
embryos of diabetic pregnancy. The reduction in number
of embryos observed in diabetic pregnancies could be due
to either reduced fecundity or early embryonic lethality
resulting from a higher malformation rate in the embryos
of diabetic mothers compared with those of non-diabetic
mothers [40]. Recently, an infant born to a type 1 diabetic
mother has been shown to exhibit axial mesodermal dys-
plasia spectrum (AMDS) with AV septal defects. However,
molecular mechanisms remain to be undefined [41]. The
morphological phenotype observed in maternal diabetes
in the present study appear similar to the features of car-
diac and extra-cardiac malformations seen in the offspring
of diabetic mothers [6,10,33]. The wide variety of cardiac
defects observed in the present study suggest a complex
pathogenesis, although several of these abnormalities
Table 3: Frequencies for cardiac and extra-cardiac 
malformations in the embryos from control and diabetic mice.
Control 
(n = 60)
Diabetes 
(n = 120)
No. of embryos with cardiac 
malformations
0 12 (10.0%)
No. of embryos with extra-cardiac 
malformationsa
0 15 (12.5%)
a Extra-cardiac malformation such as neural tube defects, including 
exencephaly, anaencephaly and spina bifida.
Table 4: Heart phenotypes of embryos obtained from diabetic 
mice.
Cardiac malformations Diabetes n/N (%)
Persistent truncus arteriosus with 
Ventricular septal defect
9/120 (7.5%)
Defective endocardial cushion 3/120 (2.5%)
n, No. of embryos with cardiac malformations; N, Total No. of 
embryos studied.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Embryos (E13 Figure 1
Embryos (E13.5) obtained from control (A-C) and diabetic (D-F) mice. Embryo from control mice shows no gross abnormali-
ties (A). In control embryos, the Ao and PT have separated (arrows) and are connected to the LV and RV respectively (connec-
tions verified by sectioning, data not shown) (B). In addition, the myocardium and trabeculae are well developed (C). High 
magnification of the superior aspect of the VS (C'). Embryo from diabetic mice shows neural tube defect (arrow) (D). In addi-
tion, there is a single outflow vessel (arrow), which is wholly committed to the RV (E). Further, the secondary ventricular 
foramen has failed to closed, histological derangements constituting the myocardium and trabeculae are observed, and the epi-
cardium is disorganized (F). High magnification of the ventricular foramen (F'). Bar C, F 500 µm; C', F' 50 µm.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Sagittal sections of the thoracic region of the whole embryos of control (A, B, E, F) and diabetic (C, D, G, H) mice showing the  immunoreactivities of PGP9 Figure 2
Sagittal sections of the thoracic region of the whole embryos of control (A, B, E, F) and diabetic (C, D, G, H) mice showing the 
immunoreactivities of PGP9.5 and NCAM. Compared with control (A, B), the number of PGP9.5 positive ganglionic cells 
appear to be reduced around the great vessels on the posterior atrial wall of experimental embryos (C, D: arrow). Inset shows 
the high magnification of the cardiac ganglionic cell expressing PGP9.5 around the great vessels on the posterior atrial wall (A). 
The NCAM immunoreactivity appears to be down-regulated in the nerves and ganglia around the atrial epicardium in the dia-
betic offspring (G, H: arrow) as compared with those of controls (E, F: arrow). In addition, the cardiac ganglionic cells express-
ing PGP9.5 and NCAM immunoreactivity in the atrial epicardium appear to be reduced in embryos of diabetic mice (H: arrow) 
when compared with controls (F: arrow). Inset shows high magnification of the cardiac ganglionic cells expressing PGP 9.5 and 
NCAM immunoreactivities in the atrial epicardium (F, H: arrow). Sketch diagrams show the lateral view of the mouse (I) and 
the sagittal view of the heart (J) indicates in figure 2A-H. Bar A, C, E, G 200 µm; B, D, F, H 50 µm.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Transverse or sagittal sections show the immunoreactivities for Bmp4 (A-F), Msx1 (G-J) and Pax3 (K-S) in the embryonic heart  of control and diabetic mice Figure 3
Transverse or sagittal sections show the immunoreactivities for Bmp4 (A-F), Msx1 (G-J) and Pax3 (K-S) in the embryonic heart 
of control and diabetic mice. Compared with control (A, B, C: arrows), the immunoreactivity for Bmp4 appears to be down-
regulated in the ventricular myocardium (D), in the OFT (E), and in cardiomyocytes overlying the EC (F: arrows) in diabetic off-
spring. In addition, experimental embryos display VSD (D: asterisk). In experimental embryos with AVC defects (I: asterisk), the 
Msx1 expression in endocardial cells in the AVC (I: arrow) and in the EC mesenchyme cells (J) appears to be reduced when 
compared to controls (G, H). Inset shows the area containing the Msx1 positive cells (G, I). In experimental embryos with VSD 
(Q: asterisk), the number of Pax3 positive cells appears to be reduced around the OFT (P), in the atrial wall (r: arrow) and in the 
EC (S: arrowhead) as compared with those of controls (K, L, M: arrow, N: arrowhead, O). Sketch diagrams show the lateral view 
of mouse (T: dotted lines indicate the orientation of cut sections in figure 3A, D, K, L, P, Q) and the sagittal view of the heart (U: indi-
cate the orientation of cut sections in figure 3B, C, E-J, M-O, R, S). Bar B, C, E, F, H, J, K, M-P, R, S 50 µm; A, D, G, I, L, Q 200 µmCardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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may result from perturbed endothelial-to-mesenchymal
transformation or abnormal development and/or migra-
tion of CNCC [42].
Maternal diabetes has been shown to induce aberrant
CNCC development in diabetic offspring [17]. A recent
study also reported that the exposure of CNCC to elevated
glucose leads to congenital heart defects [43]. CNCC play
multiple roles during heart development and are particu-
larly essential for OFT development. They are also
required for regulation of myocardial cell proliferation, as
well as differentiation and function of the myocardium
[44]. In the present study, maternal diabetes appeared to
impair the development of cardiac neural crest-derived
cardiac ganglia as revealed by the expression of PGP 9.5
and NCAM. Similar changes have been reported in vari-
ous neural crest derived tissues in high glucose environ-
ment  in vitro and  in vivo [45,46]. It seems that the
impaired development of cardiac ganglia is due to
enhanced maternal diabetes-induced apoptosis and
altered expression of genes involved in the differentiation
of cardiac ganglia.
Transforming growth factor-β (TGF-β) superfamily has
been implicated in promoting NCC induction, mainte-
nance, migration and differentiation in several model
organisms [47,48]. Bmp4 belonging to the TGFβ super-
family, is a key myocardial signaling molecule which acti-
vates EMT during cardiogenesis [49]. Bmp4  is also
essential for OFT development and regulates a crucial pro-
liferation signal for the ventricular myocardium [23].
Down-regulation of Bmp4 expression in cardiomyocytes
overlying the EC appears to have contributed to decreased
mitotic index in the EC, leading to cardiac defects in the
diabetic offspring, since mutation of Bmp4  has been
shown to reduce proliferation index in AV cushion result-
ing in AV canal defects in mice [18]. Further, Bmp4 expres-
sion has been shown to be down-regulated by the Msx1
[50], a homeobox gene expressed in AV canal endocardial
cells during EMT [51]. The timing of expression and
embryonic distribution of Msx1 parallels the timing and
distribution of Bmp4 [45]. A recent study has shown that
Msx1/2 mutant embryos exhibit defects in the cranial and
cardiac neural crest derivatives, including hypoplastic and
mispatterned cranial ganglia, dysmorphogenesis of pha-
ryngeal arch derivatives and abnormal organization of
conotruncal structures in the developing heart [19]. In
this connection, the down-regulation of Msx1 expression
and the reduced number of Msx1-positive cells in the AV
canal and the EC in the developing heart of embryos from
diabetic mice observed in the present study may be asso-
ciated with AV canal and OFT defects. Pax3, which serves
as a marker of CNCC, is also essential for the formation of
the heart and the OFT in the mouse embryo [21]. Muta-
tion of Pax3  in  Splotch  mice perturbs the neural crest
affecting development of various structures including the
outflow septum of the heart [21,22,52]. The OFT anomaly
in Splotch mice results from a deficiency in the migration
of CNCC [21,52]. In the present study, the mRNA expres-
sion of Pax3  was significantly down-regulated and the
number of Pax3 positive cells were notably reduced in the
OFT as well as in the EC in embryos of diabetic mice. This
explains the impaired development of CNCC derived tis-
sues (i.e., cardiac ganglia) observed in diabetic offspring.
Moreover, the increased number of apoptotic cells in the
OFT endocardial cushions in embryos from diabetic preg-
nancy could be due to the reduced expression of Pax3 as
down-regulation of Pax3 has been shown to cause apop-
tosis in the developing neural tube of embryos from dia-
betic mothers [40].
The present report provides the first evidence that
ultrastructural changes in cardiomyocytes of the ventricu-
lar wall may be associated with the cardiac defects
observed in embryos of diabetic pregnancy. The
ultrastructural changes in cardiomyocytes of embryos
from diabetic mice were characterized by the presence of
swollen mitochondria and disorganized myofilaments
with poorly developed adherence junctions and have
been consistent with previous observation in mutant mice
[36]. In addition, the abnormal adherence junctions with
detachment of myofilaments are as reported previously in
some transgenic mice [37]. This suggests that aberrant
myofibrillogenesis could lead to histological derange-
ments in the developing heart of diabetic pregnancy [36].
Conclusion
The present study demonstrates that maternal diabetes
alters the expression of some genes that are involved in
the development of the cardiac neural crest, leading to
congenital heart defects.
Real-time RT-PCR analysis of Bmp4, Msx1, and Pax3 mRNA  expression in the embryonic hearts of control and diabetic  mice Figure 4
Real-time RT-PCR analysis of Bmp4, Msx1, and Pax3 mRNA 
expression in the embryonic hearts of control and diabetic 
mice. Bar graph representing the fold changes of mRNA lev-
els quantified by normalization to the β-actin as an internal 
control. Mean values ± SD (n = 3). **: P < 0.001.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
Page 10 of 14
(page number not for citation purposes)
TUNEL assay shows the apoptotic cells in the embryonic heart of control (A, B) and diabetic (C, D) mice Figure 5
TUNEL assay shows the apoptotic cells in the embryonic heart of control (A, B) and diabetic (C, D) mice. Apoptotic cells 
appear to be increased in the EC (asterisk) and ventricular myocardium (arrow) in embryos of diabetic mice (c, d) as compared 
with those of controls (A, B). Inset shows high magnification of the apoptotic cells in the ventricular myocardium (B, D). Quan-
titative analysis shows that the apoptotic cells (E) are significantly increased in the developing heart of diabetic mice (filled bar). 
Bar A, B, C, D 50 µm. Mean values ± SD (n = 3). **: P < 0.001.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Cell proliferation assay showing the BrdU-labelled cells in the developing heart of embryos from control (A, B) and diabetic (C,  D) mice Figure 6
Cell proliferation assay showing the BrdU-labelled cells in the developing heart of embryos from control (A, B) and diabetic (C, 
D) mice. BrdU-labelled cells appear to be decreased in the EC (asterisk) and the ventricular myocardium (arrow) in the defec-
tive heart of experimental embryos (C, D) when compared to controls (A, B). Quantitative analysis demonstrates that the pro-
liferation index (E) is significantly decreased in the embryonic hearts of diabetic mice (filled bar). Bar A, B, C, D 50 µm. Mean 
values ± SD (n = 3). *: P < 0.05.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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Ultrastructural features of cardiomyocytes in embryos of control (A, B) and diabetic mice (C, D) Figure 7
Ultrastructural features of cardiomyocytes in embryos of control (A, B) and diabetic mice (C, D). Some mitochondria appear 
to be swollen (C) and the number of myofilaments (D: arrow) decreased in the ventricular wall of embryos from diabetic mice 
when compared to controls (A, B). Adherence junctions are less dense (asterisk), but normal desmosomes (arrowhead), and 
detachments of myofilaments (D) are found in the ventricular wall of defective heart in embryos of diabetic mice. Bar A, C 1 
µm; B, D 0.5 µm.Cardiovascular Diabetology 2007, 6:34 http://www.cardiab.com/content/6/1/34
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